{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T20:06:48Z","timestamp":1771963608273,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.toxicon.2009.01.015","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T09:25:11Z","timestamp":1233221111000},"page":"668-674","source":"Crossref","is-referenced-by-count":23,"title":["Development of future indications for BOTOX\u00ae"],"prefix":"10.1016","volume":"54","author":[{"given":"Mitchell F.","family":"Brin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2009.01.015_bib2","author":"Allergan, Inc."},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"issue":"8","key":"10.1016\/j.toxicon.2009.01.015_bib4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14656566.7.8.1085","article-title":"Botulinum toxin type A for the treatment of migraine","volume":"7","author":"Aurora","year":"2006","journal-title":"Expert. Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00365590410015867","article-title":"Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions","volume":"38","author":"Bagi","year":"2004","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"2 Pt 1","key":"10.1016\/j.toxicon.2009.01.015_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.ju.0000103274.38694.b1","article-title":"Can higher doses of oxybutynin improve efficacy in neurogenic bladder?","volume":"171","author":"Bennett","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.toxicon.2009.01.015_bib7","first-page":"241","article-title":"Botulinum toxin type A (BTX-A) for migraine: an open label assessment","volume":"13","author":"Binder","year":"1998","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1067\/mhn.2000.110960","article-title":"Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study","volume":"123","author":"Binder","year":"2000","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm","volume":"2","author":"Brin","year":"1987","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","article-title":"Refractory idiopathic urge urinary incontinence and botulinum A injection","volume":"180","author":"Brubaker","year":"2008","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.toxicon.2009.01.015_bib11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/nau.20454","article-title":"What happened when I took OAB drugs?","volume":"26","author":"Chancellor","year":"2007","journal-title":"Neurourol. Urodyn."},{"issue":"2","key":"10.1016\/j.toxicon.2009.01.015_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000079697","article-title":"Botulinum A toxin treatment of urethral sphincter pseudodyssynergia in patients with cerebrovascular accidents or intracranial lesions","volume":"73","author":"Chen","year":"2004","journal-title":"Urol. Int."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.urology.2005.04.029","article-title":"Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates","volume":"66","author":"Chuang","year":"2005","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib14","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1464-410X.2006.06479.x","article-title":"Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia","volume":"98","author":"Chuang","year":"2006","journal-title":"BJU Int."},{"issue":"7","key":"10.1016\/j.toxicon.2009.01.015_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00812153","article-title":"Local botulinum toxin in the treatment of spastic drop foot","volume":"239","author":"Dengler","year":"1992","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1185\/030079906X104614","article-title":"Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies","volume":"22","author":"Denys","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"7","key":"10.1016\/j.toxicon.2009.01.015_bib18","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1742-1241.2008.01785.x","article-title":"Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management","volume":"62","author":"Emberton","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"6 Pt 1","key":"10.1016\/j.toxicon.2009.01.015_bib19","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.ju.0000143889.00681.3f","article-title":"The effect of botulinum-A toxin on patients with severe urge urinary incontinence","volume":"172","author":"Flynn","year":"2004","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.toxicon.2009.01.015_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.eururo.2007.08.039","article-title":"Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections","volume":"53","author":"Game","year":"2008","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study","volume":"172","author":"Giannantoni","year":"2004","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib21","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0022-5347(06)00258-8","article-title":"Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity","volume":"175","author":"Giannantoni","year":"2006","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1464-4096.2001.001206","article-title":"Augmentation cystoplasty","volume":"88","author":"Greenwell","year":"2001","journal-title":"BJU Int."},{"issue":"Suppl. 4","key":"10.1016\/j.toxicon.2009.01.015_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5347(18)35521-6","article-title":"Intraprostatic botulin [botulinum] toxin injection in patients with severe benign prostatic hyperplasia: a multicenter feasibility study","volume":"173","author":"Guercini","year":"2005","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib25","first-page":"2543","article-title":"Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: initial results","volume":"12","author":"Hajebrahimi","year":"2005","journal-title":"Can. J. Urol."},{"issue":"7394","key":"10.1016\/j.toxicon.2009.01.015_bib26","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","article-title":"Effectiveness of\u00a0anticholinergic drugs compared with placebo in the treatment of\u00a0overactive bladder: systematic review","volume":"326","author":"Herbison","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.toxicon.2009.01.015_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","article-title":"Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21209","article-title":"Botulinum injections for the treatment of bladder symptoms of multiple sclerosis","volume":"62","author":"Kalsi","year":"2007","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2007.12.029","article-title":"Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity","volume":"54","author":"Kalsi","year":"2008","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.toxicon.2009.01.015_bib30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","article-title":"Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux","volume":"177","author":"Karsenty","year":"2007","journal-title":"J. Urol."},{"issue":"9","key":"10.1016\/j.toxicon.2009.01.015_bib31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1471-0528.1997.tb12054.x","article-title":"A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance","volume":"104","author":"Kelleher","year":"1997","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.toxicon.2009.01.015_bib32","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1310\/1640-XEPP-Y33E-TMK8","article-title":"Botulinum-A toxin injections as a treatment for refractory detrusor hyperreflexia","volume":"8","author":"Kennelly","year":"2003","journal-title":"Top. Spinal Cord Inj. Rehabil."},{"issue":"3","key":"10.1016\/j.toxicon.2009.01.015_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol. Urodyn."},{"issue":"11","key":"10.1016\/j.toxicon.2009.01.015_bib34","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11934-007-0046-0","article-title":"Antimuscarinics for the treatment of overactive bladder: a review of central nervous system effects","volume":"8","author":"Klausner","year":"2007","journal-title":"Curr. Urol. Rep."},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A\u00a0toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.urology.2004.10.077","article-title":"Prostate botulinum A toxin injection \u2013 an alternative treatment for benign prostatic obstruction in poor surgical candidates","volume":"65","author":"Kuo","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.toxicon.2009.01.015_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2008.04.026","article-title":"Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection","author":"Kuo","year":"2008","journal-title":"Urology"},{"issue":"Suppl. 4","key":"10.1016\/j.toxicon.2009.01.015_bib39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5347(18)35520-4","article-title":"Intraprostatic injection of botulinum toxin in the treatment of symptomatic LUTS, including sequential MRIs for accurate changes in size of the prostate","volume":"173","author":"Larson","year":"2005","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib40","first-page":"3291","article-title":"Intravesical botulinum type A toxin injection in patients with overactive bladder: trigone versus trigone-sparing injection","volume":"13","author":"Lucioni","year":"2006","journal-title":"Can. J. Urol."},{"issue":"2","key":"10.1016\/j.toxicon.2009.01.015_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/nau.20515","article-title":"Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients","volume":"27","author":"Mascarenhas","year":"2008","journal-title":"Neurourol. Urodyn."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-4610.2005.05066.x","article-title":"Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial","volume":"45","author":"Mathew","year":"2005","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.toxicon.2009.01.015_bib44","first-page":"212","volume":"148","author":"Memin","year":"1992","journal-title":"Rev. Neurol. (Paris)"},{"issue":"3","key":"10.1016\/j.toxicon.2009.01.015_bib45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/00365598409180184","article-title":"Clinical evaluation of transurethral versus transvesical prostatectomy. A randomized study","volume":"18","author":"Meyhoff","year":"1984","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"9","key":"10.1016\/j.toxicon.2009.01.015_bib46","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","article-title":"How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study","volume":"87","author":"Milsom","year":"2001","journal-title":"BJU Int."},{"issue":"Suppl. 5","key":"10.1016\/j.toxicon.2009.01.015_bib47","first-page":"S141","article-title":"BPH: costs and treatment outcomes","volume":"12","author":"Nickel","year":"2006","journal-title":"Am. J. Manag. Care"},{"issue":"10","key":"10.1016\/j.toxicon.2009.01.015_bib48","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1742-1241.2008.01880.x","article-title":"A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia","volume":"62","author":"Nickel","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2009.01.015_bib49","first-page":"53","article-title":"Medical management of benign prostatic hypertrophy","volume":"14","author":"Nix","year":"2007","journal-title":"Can. J. Urol."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib50","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.eururo.2008.06.016","article-title":"Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature","volume":"54","author":"Oeconomou","year":"2008","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib51","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3349\/ymj.2006.47.5.706","article-title":"Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia","volume":"47","author":"Park","year":"2006","journal-title":"Yonsei Med. J."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ncpuro1060","article-title":"Medical management of lower urinary tract symptoms in men: current treatment and future approaches","volume":"5","author":"Patel","year":"2008","journal-title":"Nat. Clin. Pract. Urol."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","article-title":"Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction","volume":"165","author":"Phelan","year":"2001","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.toxicon.2009.01.015_bib54","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","article-title":"A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib55","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"issue":"3 Pt 1","key":"10.1016\/j.toxicon.2009.01.015_bib56","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","article-title":"Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder","volume":"175","author":"Rapp","year":"2006","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib57","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur. Urol."},{"issue":"2 Pt 1","key":"10.1016\/j.toxicon.2009.01.015_bib58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib59","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8","article-title":"Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection","volume":"19","author":"Rosales","year":"1996","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib60","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11934-002-0093-5","article-title":"Incidence and prevalence of overactive bladder","volume":"3","author":"Rovner","year":"2002","journal-title":"Curr. Urol. Rep."},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib61","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","article-title":"Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial","volume":"177","author":"Sahai","year":"2007","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid","year":"2006","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.toxicon.2009.01.015_bib64","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","article-title":"Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction","volume":"48","author":"Schulte-Baukloh","year":"2005","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib65","first-page":"183","article-title":"Treatment of tension-type headache with botulinum toxin: a pilot study","volume":"4","author":"Schulte-Mattler","year":"1999","journal-title":"Eur. J. Med. Res."},{"issue":"3 Pt 1","key":"10.1016\/j.toxicon.2009.01.015_bib67","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/00005392-200009010-00018","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib66","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0302-2838(02)00209-9","article-title":"Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease","volume":"42","author":"de Seze","year":"2002","journal-title":"Eur. Urol."},{"issue":"9","key":"10.1016\/j.toxicon.2009.01.015_bib68","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4065\/80.9.1126","article-title":"Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial","volume":"80","author":"Silberstein","year":"2005","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eururo.2007.08.050","article-title":"Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption","volume":"53","author":"Silva","year":"2008","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.47102\/annals-acadmedsg.V36N1p11","article-title":"Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore","volume":"36","author":"Tow","year":"2007","journal-title":"Ann. Acad. Med. Singapore"},{"issue":"4","key":"10.1016\/j.toxicon.2009.01.015_bib72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1017\/S031716710003540X","article-title":"A pilot study on the use of botulinum toxin in spasmodic torticollis","volume":"12","author":"Tsui","year":"1985","journal-title":"Can. J. Neurol. Sci."},{"issue":"8501","key":"10.1016\/j.toxicon.2009.01.015_bib73","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2009.01.015_bib1","author":"Tufts Center for the Study of Drug Development"},{"issue":"5","key":"10.1016\/j.toxicon.2009.01.015_bib74","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","article-title":"Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study","volume":"192","author":"Werner","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.toxicon.2009.01.015_bib75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/02813439709043428","article-title":"Prostate symptoms in general practice: seriousness and inconvenience","volume":"15","author":"Wille-Gussenhoven","year":"1997","journal-title":"Scand. J. Prim. Health Care"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010109000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010109000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T20:06:59Z","timestamp":1684872419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010109000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0041010109000415"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2009.01.015","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}